At a glance
- Originator Merck KGaA
- Developer Merck KGaA; Nonindustrial source; Roche Palo Alto LLC
- Class Cardiotonics; Small molecules
- Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Heart failure